News | LSHTM

Close

LSHTM

Found 0 results for your search. Showing 0 to 0.

No results could be found for your search.

Close

News

A reduced two-dose schedule sustains protection for children and their caregivers, ensuring the future financial sustainability of vital immunisation programmes. Billy Quilty Honorary Research Fellow LSHTM

Two pneumococcal vaccine doses provide comparable long-term protection to three, researchers say

Wednesday 10 June 2026

Quote from Andy Clark: “Our updated estimates show that many children in LMICs continue to receive vaccines much later than the recommended target age.”

Vaccines delayed for many children in nearly 100 countries

Monday 1 June 2026

Graphical depicition of Ebola virus. Credit LSHTM

Q&A: Bundibugyo Ebola outbreak in DRC and Uganda – where are the vaccines?

Wednesday 20 May 2026

A graphic representing meningitis (inflammation of membranes surrounding the brain)

Rapid reaction: Reading meningitis outbreak: what do we know?

Friday 15 May 2026

Health worker in mask draws a dose of RTS,S malaria vaccine from a vial into a syringe.

Expert comment: Malaria vaccine averts 1 in 8 deaths in young children

Friday 8 May 2026

People sitting around round tables, listening to someone standing at lecturn giving presentation in hotel conference room.

Vaccine Centre holds retreat highlighting the importance of vaccines for safeguarding health

Thursday 30 April 2026

Daniela Manno: This vaccine can cause long-term immune response, something especially important as Ebola outbreaks are often not recognised early. Rapid immunity from vaccines during outbreaks will be vital to preventing future spread.

Ebola vaccine provides long-term immune responses against deadly virus, helping inform future outbreak responses

Wednesday 29 April 2026

“Antibiotic prescriptions for typhoid fever should be informed by up-to-date, evidence-based resistance patterns. In situations where access to newer antibiotics is limited, older ones can still work if tests show the bacteria are sensitive. Systematic research and continuous surveillance of antibiotic resistance patterns are critical for effective typhoid control.” - Dr Vijayalaxmi Mogasale, Joint PhD Candidate, LSHTM-Nagasaki University

New study shows shifting typhoid resistance in India

Tuesday 28 April 2026

A graphic representing meningitis (inflammation of membranes surrounding the brain)

Rapid reaction: Do I need the MenB vaccine?

Tuesday 24 March 2026

“Typhoid fever and its associated antibiotic resistance impose a considerable financial burden on the nation and on affected Indian households. For many, out-of-pocket costs for typhoid treatment are so high that they limit their ability to meet basic livelihood needs. Implementing vaccination programmes, responsible antibiotic use, and expanding social health insurance coverage can mitigate the economic impact of this disease at the national level.” Dr Vijayalaxmi Mogasale, Joint PhD Candidate, LSHTM-Naga

Typhoid fever costs billions for India’s economy and people

Tuesday 24 March 2026

“Meningitis is now very rare in the UK in the era of vaccination but there are still cases every year.” Eliza Gil, Clinical Lecturer, LSHTM

Rapid reaction: What is meningitis B?

Tuesday 17 March 2026

"This is a worrying time for parents and the immediate priority is to ensure that all children catch-up on any missed vaccinations." Ben Kasstan-Dabush, Assistant Professor of Global Health & Development, LSHTM

Rapid reaction: Could a measles outbreak in London affect me?

Friday 27 February 2026